Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 23
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

Role of Cyclooxygenase-2 in Ischemia-Reperfusion Injury in the Liver

  • Fuertes Agudo, Marina
[ES] La lesión por isquemia-reperfusión (I/R) hepática (IRI) es una causa importante de mortalidad y morbilidad en la resección hepática y el trasplante de hígado. Durante la hipoxia, el hígado permanece sin oxígeno, cambiando su metabolismo y parando la síntesis de ATP. Paradójicamente, el restablecimiento del flujo de oxígeno causa más daño, activando el sistema inmunitario que generará una gran cantidad de especies reactivas de oxígeno (ROS) causando daño celular y tisular. La ciclooxigenasa-2 (COX-2) es una enzima clave en la biosíntesis de prostaglandinas y su importancia en la IRI es controvertida. La PGE2, prostaglandina E2, es el principal producto de la COX-2, y participa en la mediación de procesos patológicos como la inflamación, la fiebre y el dolor. El uso de AINEs, inhibidores específicos de la COX, apunta a un efecto beneficioso en la resolución del proceso inflamatorio, pero cada vez más estudios apoyan el papel antiinflamatorio de la COX-2. De hecho, estudios previos han demostrado que la sobreexpresión de COX-2 en hepatocitos protege a los ratones de la apoptosis y el estrés celular, además de reducir la respuesta inflamatoria en diferentes modelos de enfermedad hepática. En esta tesis doctoral, se utilizó un ratón transgénico que sobreexpresa COX-2 en los hepatocitos (h-COX-2 Tg) para dilucidar el papel y la implicación de la COX-2 en la IRI. Los animales de tipo silvestre (Wt) y h-COX-2 Tg fueron sometidos a 90 min de isquemia, seguidos de 4 o 24 h de reperfusión. Comparando los animales h-COX-2 Tg con sus hermanos Wt, el daño celular y tisular se atenúa tras la IRI. Entre las distintas vías modificadas, la cascada inflamatoria está menos activada, con menor liberación de citoquinas pro-inflamatorias, menor reclutamiento hepático, e infiltración de neutrófilos. Las vías de necrosis y apoptosis también se atenúan así como se reduce del estrés del retículo endoplásmico, y aumenta la autofagia. La respuesta antioxidante se potencia en el contexto de la sobreexpresión de COX-2 y la producción total de ROS es menor, lo que contribuye a un menor daño tisular. Cuando los animales Wt se someten un pre-condicionamiento (PC), la COX-2 endógena se induce a niveles más altos que sin PC, mostrando menos daño, una inflamación atenuada, y una respuesta antioxidante mejorada. Además, se muestra que el papel de la COX-2 en esta protección es específico, ya que su inhibición con DFU revierte los efectos observados e iguala el daño causado a los animales Wt. Las mitocondrias son actores centrales en la fisiopatología de la IRI. En este sentido, la función mitocondrial está preservada en los hígados que sobreexpresan COX-2, con un potencial de membrana mitocondrial conservado y una tasa respiratoria preservada. Estos efectos pueden explicarse por una estabilización de las crestas mitocondriales, invaginaciones de la membrana mitocondrial interna (IMM) que se mantienen mediante interacciones de varias isoformas de la proteína OPA1. Su procesamiento está mediado por proteasas, como OMA1. En ratones h-COX-2 Tg hay un menor procesamiento de OPA1, que se correlaciona con una actividad atenuada de OMA1. Por otro lado, se realizó un estudio retrospectivo en pacientes que habían sido sometidos a un trasplante hepático. Se analizaron los niveles de PGE2 y se correlacionaron con las funciones hepáticas tras el trasplante. Este análisis muestra que la presencia de PGE2 en el plasma de los pacientes receptores se correlaciona con un mejor pronóstico, mientras que unos niveles más bajos de PGE2 se asocian con una disfunción precoz del injerto. Todos estos resultados presentan a la COX-2 como un nuevo actor en la protección del hígado tras I/R, mostrando un papel antiinflamatorio y antioxidante, así como reduciendo el daño mitocondrial, el estrés celular y la muerte celular. Además, se demuestra cómo las prostaglandinas derivadas de la COX-2 en condiciones fisiológicas pueden desempeñar un papel protector en casos de trasplante hepático., [CA] La lesió per isquèmia-reperfusió (I/R) hepàtica (IRI) és una causa important de mortalitat i morbiditat en la resecció hepàtica i el trasplantament de fetge. Durant la hipòxia, el fetge roman sense oxigen, canviant el seu metabolisme i aturant la síntesi d'ATP. Paradoxalment, el restabliment del flux d'oxigen causa més danys, activant el sistema immunitari que genera una gran quantitat d'espècies reactives d'oxigen (ROS) causant dany cel·lular i tissular. La ciclooxigenasa-2 (COX-2) és un enzim clau en la biosíntesi de prostaglandines i la seva importància a l'IRI és controvertida. La PGE2, prostaglandina E2, és el principal producte de la COX-2, i participa en la mediació de processos patològics com la inflamació i la febre. Mentre que l'ús d'AINEs, inhibidors específics de la COX-2, apunta a un efecte beneficiós en la resolució del procés inflamatori, cada cop més estudis donen suport a un paper antiinflamatori de la COX-2. De fet, estudis previs han demostrat que la sobreexpressió de COX-2 en hepatòcits protegeix els ratolins de l'apoptosi i l'estrès cel·lular, a més de reduir la resposta inflamatòria, en diferents models de malaltia hepàtica. En aquesta tesi, s'ha utilitzat un ratolí transgènic que sobreexpressa la COX-2 en els hepatòcits (h-COX-2 Tg) per dilucidar el paper i la implicació de la COX-2 a l'IRI. Els animals de tipus silvestre (Wt) i h-COX-2 Tg van ser sotmesos a 90 min d'isquèmia, seguits de 4 o 24 h de reperfusió. Comparant els animals h-COX-2 Tg amb els seus germans Wt, el dany cel·lular i tissular s'atenua després de l'IRI. Entre les diferents vies modificades, la cascada inflamatòria està menys activada, s'alliberen menys citocines proinflamatòries , hi ha un menor reclutament hepàtic i menor infiltració de neutròfils. Les vies de necrosi i apoptosi també s'atenuen, així com es redueix l'estrès del reticle endoplasmàtic, i l'autofàgia augmenta. La resposta antioxidant es potencia i la producció total de ROS també és menor, fet que contribueix a un menor dany tissular. Quan els animals Wt se sotmeten a un precondicionament (PC), la COX-2 endògena s'indueix a nivells més alts que sense PC, i aquests fetges mostren menys dany, una inflamació atenuada i una resposta antioxidant millorada. A més, es mostra que el paper de la COX-2 en aquesta protecció és específic, ja que la seva inhibició amb DFU, reverteix els efectes observats i iguala el dany causat als animals Wt. Els mitocondris són actors centrals en la fisiopatologia de l'IRI. En aquest sentit, la funció mitocondrial és preservada als fetges que sobreexpressen COX-2, com es pot demostrar per un potencial de membrana mitocondrial conservat i una taxa respiratòria preservada. Aquests efectes es poden explicar per una estabilització de les crestes mitocondrials, invaginacions de la membrana mitocondrial interna (IMM) que es mantenen mitjançant interaccions de diverses isoformes d'OPA1, una proteïna de la IMM. El seu processament està mediat per proteasas, com OMA1. En ratolins h-COX-2 Tg hi ha un menor processament d'OPA1, que es correlaciona amb una activitat atenuada d'OMA1, mostrant una estabilització de les crestes. D'altra banda, es va fer un estudi retrospectiu amb pacients que havien estat sotmesos a un trasplantament hepàtic. Es van analitzar els nivells de PGE2 i es van correlacionar amb les funcions hepàtiques després del trasplantament. Aquesta anàlisi mostra que la presència de PGE2 en el plasma dels pacients receptors es correlaciona amb un millor pronòstic, mentre que uns nivells més baixos de PGE2 s'associen amb una disfunció precoç de l'empelt. Tots aquests resultats presenten a la COX-2 com un nou actor en la protecció del fetge després d'I/R, mostrant un paper antiinflamatori i antioxidant, així com reduint la lesió mitocondrial, l'estrès cel·lular i la mort cel·lular. A més, es demostra com les prostaglandines derivades de la COX-2 en condicions fisiològiques poden exercir un paper protector en casos de trasplantament hepàtic., [EN] Hepatic ischemia-reperfusion (I/R) injury (IRI) is a major cause of mortality and morbidity in liver resection and liver transplantation. During the hypoxia, the liver remains without oxygen supply, shifting its metabolism and stopping the ATP synthesis. Paradoxically, the restoration of oxygen flow causes the most damage with an activation of the immune system that will generate a burst of reactive species of oxygen (ROS) that will cause cell and tissue damage. Cyclooxygenase-2 (COX-2) is a key enzyme in prostaglandin biosynthesis and its importance in IRI is controversial. PGE2, prostaglandin E2, is the main product of COX-2, and is mainly involved in mediating pathological processes such as inflammation, fever and pain. While the use of NSAIDs, specific COX inhibitors, points to a beneficial effect in the resolution of the inflammatory process, several studies support the idea of an anti-inflammatory role of COX-2. In fact, previous studies have shown that COX-2 overexpression in hepatocytes protects mice from apoptosis and cellular stress, as well as reducing the inflammatory response, in different liver disease models. In this PhD thesis, a hepatocyte-specific COX-2 transgenic mouse (h-COX-2 Tg) was used to elucidate the role and involvement of COX-2 in IRI. Wild type (Wt) and h-COX-2 Tg animals were subjected to 90 min of ischemia, followed by 4 or 24 h of reperfusion. Comparing h-COX-2 Tg animals with their Wt littermates, cellular and tissue damage resulting from IRI is attenuated. Among these pathways, the inflammatory cascade is less activated, with less pro-inflammatory cytokine release, less hepatic recruitment and neutrophil infiltration. Necrosis and apoptosis pathways are also attenuated such as reduced endoplasmic reticulum stress, and increased autophagy. The antioxidant response appears to be enhanced in the context of COX-2 overexpression and total ROS production is also lower, contributing to less tissue damage. When Wt animals are subjected to preconditioning (PC), endogenous COX-2 is induced at higher levels than without PC, and these livers show less damage, attenuated inflammation, and an enhanced antioxidant response. Furthermore, the role of COX-2 in this observed protection has been shown to be specific, as its inhibition with DFU, reverses the observed effects, and matched the damage caused to Wt animals. Mitochondria are central players in the pathophysiology of IRI. In this regard, mitochondrial function is preserved in COX-2-overexpressing livers, as can be demonstrated by a conserved mitochondrial membrane potential and a preserved respiratory rate. These results can be explained by a stabilisation of mitochondrial cristae, invaginations of the inner mitochondrial membrane (IMM) that maintained through interactions of various isoforms of OPA1. Its processing is mediated by proteases, such as OMA1, which acts under certain stimuli. In h-COX-2 Tg mice, there is a reduced OPA1 processing that correlates with attenuated OMA1 activity, showing a stabilisation of cristae in the context of COX-2 overexpression after I/R. On the other hand, a retrospective study was conducted in patients who had undergone liver transplantation. In this part of the study, PGE2 levels were analysed and correlated with liver functions after transplantation. This analysis shows that the presence of PGE2 in the plasma of recipients correlates with a better prognosis, while lower PGE2 levels are associated with early graft dysfunction. All these results present COX-2 as a new player in liver protection after I/R, showing an anti-inflammatory and antioxidant role, as well as reducing mitochondrial damage, cell stress and cell death. Furthermore, it is shown how COX-2-derived prostaglandins under physiological conditions can play a protective role in cases of liver transplant., This work has been carried out with the financial support of the Spanish Ministry of Science and Innovation (SAF2016-75004R and PID2019-108977RB-100), the CIBERehd (Centro de Investigaciones Biomédicas En Red de Enfermedades Hepáticas y Digestivas) and the COST Action (CA15203 - Mitochondrial mapping: Evolution - Age - Gender - Lifestyle - Environment (MITOEAGLE)). Marina Fuertes Agudo benefited from a pre-doctoral FPI contract (BES-2017- 081928) associated with the SAF2016-75004R project. She spent 3 months in the laboratory of Dr. Pau Sancho Bru at the Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS, Barcelona, Spain) funded by a short stay grant awarded by the CIBERehd and 3 months in the laboratory of Dr. Anne Dubart Kupperschmitt and Dr. Jean Charles Duclos Vallée at the Institut Nationale de la Santé et la Recherche Médicale (INSERM, Villejuif, France) funded by a short stay grant awarded by the European Molecular Biology Organisation (EMBO, SEG_9771).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives

  • Martín-Sanz, Paloma
  • Casado, Marta
  • Boscá, Lisardo
The biosynthesis of prostaglandins and thromboxanes has been a focus of interest in the management of many liver diseases. Cyclooxygenases are the enzymes involved in the first step of the biosynthesis of these lipid mediators and selective inhibitors for these isoenzymes as well as pharmacological analogues of prostaglandins have been developed and are currently applied therapeutically. Here we discuss the implications of these enzymes in the onset of metabolic and lipid disorders in the liver and their potential role in the progression of the diseases towards fibrosis and hepatocellular carcinogenesis., Supported by MINECO, Spain, No. SAF2014-52492R; COOPB20213 (CSIC), No. SAF2013-43713R and No. SAF2016-75004R; ISCIII, Spain, CIBERcv and CIBERehd; We thank FEDER for financial support., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Defects in the mitochondrial-tRNA modification enzymes MTO1 and GTPBP3 promote different metabolic reprogramming through a HIF-PPARγ-UCP2-AMPK axis

  • Boutoual, Rachid
  • Meseguer, Salvador
  • Villarroya, Magda
  • Martín-Hernández, Elena
  • Errami, Mohammed
  • Martín, Miguel A.
  • Casado, Marta
  • Armengod, M.-Eugenia
18 páginas 8 figuras. Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-19587-5., Human proteins MTO1 and GTPBP3 are thought to jointly catalyze the modification of the wobble uridine in mitochondrial tRNAs. Defects in each protein cause infantile hypertrophic cardiomyopathy with lactic acidosis. However, the underlying mechanisms are mostly unknown. Using fibroblasts from an MTO1 patient and MTO1 silenced cells, we found that the MTO1 deficiency is associated with a metabolic reprogramming mediated by inactivation of AMPK, down regulation of the uncoupling protein 2 (UCP2) and transcription factor PPARγ, and activation of the hypoxia inducible factor 1 (HIF-1). As a result, glycolysis and oxidative phosphorylation are uncoupled, while fatty acid metabolism is altered, leading to accumulation of lipid droplets in MTO1 fibroblasts. Unexpectedly, this response is different from that triggered by the GTPBP3 defect, as GTPBP3-depleted cells exhibit AMPK activation, increased levels of UCP2 and PPARγ, and inactivation of HIF-1. In addition, fatty acid oxidation and respiration are stimulated in these cells. Therefore, the HIF-PPARγ-UCP2-AMPK axis is operating differently in MTO1- and GTPBP3-defective cells, which strongly suggests that one of these proteins has an additional role, besides mitochondrial-tRNA modification. This work provides new and useful information on the molecular basis of the MTO1 and GTPBP3 defects and on putative targets for therapeutic intervention., Tis work has been supported by grants from the Spanish Ministry of Economy and Competitiveness (grants BFU2010-19737 and BFU2014-58673-P to M.-E.A.; and SAF2016-75004-R to M.C.), Instituto de Salud Carlos III (FIS-ISCIII PI 14/0431 to M.A.M) and Generalitat Valenciana (ACOMP/2012/065 and PROMETEO/2012/061 to M.-E.A. Contribution to COST Action CA15203 MITOEAGLE. R.B. is a recipient of a fellowship from the Generalitat Valenciana (grant GRISOLIA/2014/038). Te authors thank Dr. E. Knecht and Dr. C. Aguado (CIPF, Valencia, Spain) for their valuable advice and for providing facilities in our research work, and Dr. M. Morán (Hospital 12 de Octubre, Madrid, Spain) for growth and maintenance of patient fbroblasts., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Astrocytes: new players in progressive myoclonus epilepsy of Lafora type

  • Rubio-Villena, Carla
  • Viana, Rosa
  • Bonet, Jose
  • García-Gimeno, María Adelaida
  • Casado, Marta
  • Heredia, Miguel
  • Sanz, Pascual
11 páginas, 7 figuras. This is a pre-copyedited, author-produced version of an article accepted for publication in Human Molecular Genetics following peer review. The version of record Rubio-Villena C., Viana R., Bonet J., Garcia-Gimeno M.A., Casado M., Heredia M.,Sanz P. (2018). Astrocytes: new players in progressive myoclonus epilepsy of Lafora type. Hum Mol Genet 27(7): 1290-1300, is available online at: http://dx.doi.org/10.1093/hmg/ddy044, Lafora disease (LD) is a fatal form of progressive myoclonus epilepsy characterized by the accumulation of insoluble poorly branched glycogen-like inclusions named Lafora bodies (LBs) in the brain and peripheral tissues. In the brain, since its first discovery in 1911, it was assumed that these glycogen inclusions were only present in affected neurons. Mouse models of LD have been obtained recently, and we and others have been able to report the accumulation of glycogen inclusions in the brain of LD animals, what recapitulates the hallmark of the disease. In this work we present evidence indicating that, although in mouse models of LD glycogen inclusions co-localize with neurons, as originally established, most of them co-localize with astrocytic markers such as glial fibrillary acidic protein (GFAP) and glutamine synthase. In addition, we have observed that primary cultures of astrocytes from LD mouse models accumulate higher levels of glycogen than controls. These results suggest that astrocytes may play a crucial role in the pathophysiology of Lafora disease, as the accumulation of glycogen inclusions in these cells may affect their regular functionality leading them to a possible neuronal dysfunction., This work was supported by grants from the Spanish Ministry of Economy and Competitiveness SAF2014-54604-C3-1-R, a grant from Generalitat Valenciana (PrometeoII/2014/029), a grant form Fundación Ramón Areces (XVIII Concurso Nacional Ayudas Investigacion Ciencias Vida y Materia) and a grant from the National Institute of Health (NIH-NINDS) P01NS097197, which established the Lafora Epilepsy Cure Initiative (LECI), to PS and grants SAF2016-75004-R and Contribution to COST Action CA15203 MITOEAGLE to MC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Protection against gamma-radiation injury by protein tyrosine phosphatase 1B

  • Mojena, Marina
  • Pimentel-Santillana, María
  • Povo-Retana, Adrián
  • Fernández-García, Victoria
  • González-Ramos, Silvia
  • Rada, Patricia
  • Tejedor, Alberto
  • Rico, Daniel
  • Martín-Sanz, Paloma
  • Valverde, Ángela M.
  • Boscá, Lisardo
Protein tyrosine phosphatase 1B (PTP1B) is widely expressed in mammalian tissues, in particular in immune cells, and plays a pleiotropic role in dephosphorylating many substrates. Moreover, PTP1B expression is enhanced in response to pro-inflammatory stimuli and to different cell stressors. Taking advantage of the use of mice deficient in PTP1B we have investigated the effect of γ-radiation in these animals and found enhanced lethality and decreased respiratory exchange ratio vs. the corresponding wild type animals. Using bone-marrow derived macrophages and mouse embryonic fibroblasts (MEFs) from wild-type and PTP1B-deficient mice, we observed a differential response to various cell stressors. PTP1B-deficient macrophages exhibited an enhanced response to γ-radiation, UV-light, LPS and S-nitroso-glutathione. Macrophages exposed to γ-radiation show DNA damage and fragmentation, increased ROS production, a lack in GSH elevation and enhanced acidic β-galactosidase activity. Interestingly, these differences were not observed in MEFs. Differential gene expression analysis of WT and KO macrophages revealed that the main pathways affected after irradiation were an up-regulation of protein secretion, TGF-β signaling and angiogenesis among other, and downregulation of Myc targets and Hedgehog signaling. These results demonstrate a key role for PTP1B in the protection against the cytotoxicity of irradiation in intact animal and in macrophages, which might be therapeutically relevant., This work was supported by grants SAF2017-82436R, SAF2016-75004R and SAF2015-65267 from MINIECO, S2017/BMD-3686 and BMD3684 from Comunidad de Madrid, Fundación Ramón Areces (2016/CIVP18A3864) and Cibercv, Ciberdem and Ciberehd (funded by the Instituto de Salud Carlos III and by Fondos FEDER). We also acknowledge H2020 Marie Sklodowska-Curie ITN-TREATMENT (Grant Agreement number 721236) (European Commission). P.R. was recipient a Juan de la Cierva postdoctoral contract from MINIECO (IJCI-2014-19381)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Cyclooxygenase-2 expression in hepatocytes protects against hepatic ischemia-reperfusion injury in mice

  • Motiño, Omar
  • Francés, Daniel E.
  • Casanova, Natalia
  • Cucarella, Carme
  • Fuertes-Agudo, Marina
  • Flores, Juana María
  • Olmedilla, Luis
  • Pérez Peña, José
  • Bañares, Rafael
  • Boscá, Lisardo
  • Casado, Marta
  • Martín-Sanz, Paloma
Póster presentado al XLI Congreso de la SEBBM. Santander, 10-13 de septiembre de 2018, Comunicación núm. 6. Liver ischemia and reperfusion injury (IRI) remains a serious clinical problem affecting liver transplantation outcomes. IRI causes up to 10% of early organ failure and predisposes to chronic rejection. Cyclooxygenase-2 (COX-2) is involved in different liver diseases but the significance of COX-2 in liver IRI is a matter of controversy. This study was designed to elucidate the role of COX-2 expression in hepatocytes in the pathogenesis of liver IRI. In the present work hepatocyte-specific COX-2 transgenic mice (hCOX-2-Tg) and their wild-type (Wt) littermates were subjected to partial IRI and the results show that hCOX-2-Tg exhibited lower grades of necrosis and inflammation than Wt mice in part by reduced recruitment and infiltration of hepatic macrophages and netrophils with a corresponding decrease in serum levels of pro-inflammatory cytokines. Moreover hCOX-2-Tg mice showed a significant attenuation of the IRI-induced increase in oxidative stress and hepatic apoptosis an increase in autophagic flux and a decrease in endoplasmic reticulum (ER) stress comparing with that observed in Wt mice. Preconditioning of Wt mice resembles the beneficial effects of hCOX-2-Tg mice in IRI due to an increase in endogenous COX-2 expression. Furthermore measurement of PGE2 levels in plasma from patients who underwent orthotopic liver transplantation revealed a significantly negative correlation between PGE2 levels and graft function and time of ischemia. Overall the data support the view of the beneficial effects of hepatic COX-2 dependent prostaglandins after liver IRI., This work was supported by i‐COOP2016‐20213 (CSIC) to D.F., P.M.S; SAF2014‐52492 (MINECO, Spain) to L.B.; CIBERcv and CIBERehd (ISCIII, Spain) to L.B., P.M.S and M.C.; SAF2016‐75004‐R (MINECO, Spain) to P.M.S. and M.C. M F‐A. is recipient of FPI fellowship from MINECO (BES‐2017‐081928)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Post-translational modifications of prostaglandin-endoperoxide synthase 2 in colorectal cancer: An update

  • Jaén, Rafael I.
  • Prieto, Patricia
  • Casado, Marta
  • Martín-Sanz, Paloma
  • Boscá, Lisardo
The biosynthesis of prostanoids is involved in both physiological and pathological processes. The expression of prostaglandin-endoperoxide synthase 2 (PTGS2; also known as COX-2) has been traditionally associated to the onset of several pathologies, from inflammation to cardiovascular, gastrointestinal and oncologic events. For this reason, the search of selective PTGS2 inhibitors has been a focus for therapeutic interventions. In addition to the classic non-steroidal anti-inflammatory drugs, selective and specific PTGS2 inhibitors, termed coxibs, have been generated and widely used. PTGS2 activity is less restrictive in terms of substrate specificity than the homeostatic counterpart PTGS1, and it accounts for the elevated prostanoid synthesis that accompanies several pathologies. The main regulation of PTGS2 occurs at the transcription level. In addition to this, the stability of the mRNA is finely regulated through the interaction with several cytoplasmic elements, ranging from specific microRNAs to proteins that control mRNA degradation. Moreover, the protein has been recognized to be the substrate for several post-translational modifications that affect both the enzyme activity and the targeting for degradation via proteasomal and non-proteasomal mechanisms. Among these modifications, phosphorylation, glycosylation and covalent modifications by reactive lipidic intermediates and by free radicals associated to the pro-inflammatory condition appear to be the main changes. Identification of these post-translational modifications is relevant to better understand the role of PTGS2 in several pathologies and to establish a correct analysis of the potential function of this protein in diseases progress. Finally, these modifications can be used as biomarkers to establish correlations with other parameters, including the immunomodulation dependent on molecular pathological epidemiology determinants, which may provide a better frame for potential therapeutic interventions., Supported by Ministerio de Ciencia Innovación y Universidades, No. SAF2017-82436R and SAF2016-75004R; Comunidad de Madrid, No. S2017/BMD-3686; Fundación Ramón Areces, No. 2016/CIVP18A3864; and Instituto de Salud Carlos III and by Fondos FEDER, No. Cibercv and Ciberehd, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Benzylamine and thenylamine derived drugs induce apoptosis and reduce proliferation, migration and metastasis formation in melanoma cells

  • Mojena, Marina
  • Povo-Retana, Adrián
  • González-Ramos, Silvia
  • Fernández-García, Victoria
  • Regadera, Javier
  • Zazpe, Arturo
  • Artaiz, Inés
  • Martín-Sanz, Paloma
  • Ledo, Francisco
  • Boscá, Lisardo
Melanomas are heterogeneous and aggressive tumors, and one of the worse in prognosis. Melanoma subtypes follow distinct pathways until terminal oncogenic transformation. Here, we have evaluated a series of molecules that exhibit potent cytotoxic effects over the murine and human melanoma cell lines B16F10 and MalMe-3M, respectively, both ex vivo and in animals carrying these melanoma cells. Ex vivo mechanistic studies on molecular targets involved in melanoma growth, migration and viability were evaluated in cultured cells treated with these drugs which exhibited potent proapoptotic and cytotoxic effects and reduced cell migration. These drugs altered the Wnt/β-catenin pathway, which is important for the oncogenic phenotype of melanoma cells. In in vivo experiments, male C57BL/6 or nude mice were injected with melanoma cells that rapidly expanded in these animals and, in some cases were able to form metastasis in lungs. Treatment with anti-tumor drugs derived from benzylamine and 2-thiophenemethylamine (F10503LO1 and related compounds) significantly attenuated tumor growth, impaired cell migration, and reduced the metastatic activity. Several protocols of administration were applied, all of them leading to significant reduction in the tumor size and enhanced animal survival. Tumor cells carrying a luciferase transgene allowed a time-dependent study on the progression of the tumor. Molecular analysis of the pathways modified by F10503LO1 and related compounds defined the main relevant targets for tumor regression: the activation of pro-apoptotic and anti-proliferative routes. These data might provide the proof-of-principle and rationale for its further clinical evaluation., This work was supported by grants CENIT-Pharma, SAF2017-82436R and SAF2016-75004R from MINEICO, S2017/BMD-3686 from Comunidad de Madrid, CIVP18A3864 from Fundación Ramón Areces and Cibercv and Ciberehd (funded by the Instituto de Salud Carlos III) and Fondos FEDER., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet

  • Lambertucci, Flavia
  • Arboatti, Ainelén
  • Sedlmeier, María Guillermina
  • Motiño, Omar
  • Alvarez, María de Luján
  • Ceballos, María Paula
  • Villar, Silvina R.
  • Roggero, Eduardo
  • Monti, Juan A.
  • Pisani, Gerardo
  • Quiroga, Ariel D.
  • Martín-Sanz, Paloma
  • Carnovale, Cristina E.
  • Eleazar Francés, Daniel
  • Ronco, María Teresa
Obesity is accompanied by a low-grade inflammation state, characterized by increased proinflammatory cytokines levels such as tumor necrosis factor alpha (TNFα) and interleukin-1 beta (IL-1β). In this regard, there exists a lack of studies in hepatic tissue about the role of TNFα receptor 1 (TNFR1) in the context of obesity and insulin resistance during the progression of nonalcoholic fatty liver disease (NAFLD). The aim of this work was to evaluate the effects of high-caloric feeding (HFD) (40% fat, for 16 weeks) on liver inflammation-induced apoptosis, insulin resistance, hepatic lipid accumulation and its progression toward nonalcoholic steatohepatitis (NASH) in TNFR1 knock-out and wild-type mice. Mechanisms involved in HFD-derived IL-1β release and impairment of insulin signaling are still unknown, so we determined whether IL-1β affects liver insulin sensitivity and apoptosis through TNFα receptor 1 (TNFR1)-dependent pathways. We showed that knocking out TNFR1 induces an enhanced IL-1β plasmatic release upon HFD feed. This was correlated with higher hepatic and epididymal white adipose tissue mRNA levels. In vivo and in vitro assays confirmed an impairment in hepatic insulin signaling, in part due to IL-1β-induced decrease of AKT activation and diminution of IRS1 levels, followed by an increase in inflammation, macrophage (resident and recruited) accumulation, hepatocyte apoptotic process and finally hepatic damage. In addition, TNFR1 KO mice displayed higher levels of pro-fibrogenic markers. TNFR1 signaling disruption upon an HFD leads to an accelerated progression from simple steatosis to a more severe phenotype with many NASH features, pointing out a key role of TNFR1 in NAFLD progression., This work was supported by research grants from Consejo Nacional de Investigaciones Científicas y Técnicas (PIP-CONICET 112201500508, to C.E.C.) and SAF2016-75004-R and SAF2015-70270-REDT (MINECO, Spain)to P.M.S. and O.M., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

PGE2 induces apoptosis of hepatic stellate cells and attenuates liver fibrosis in mice by downregulating miR-23a-5p and miR-28a-5p

  • Brea, Rocío
  • Motiño, Omar
  • Francés, Daniel E.
  • García-Monzón, Carmelo
  • Vargas, Javier
  • Fernández-Velasco, María
  • Boscá, Lisardo
  • Casado, Marta
  • Martín-Sanz, Paloma
  • Agra, Noelia
Título del pdf-manuscrito: PGE2 attenuates liver fibrosis in mice by downregulating miR-23a- 5p and inducing apoptosis of hepatic stellate cells., MicroRNAs (miRNAs), small noncoding RNAs modulating messenger RNA (mRNA) and protein expression, have emerged as key regulatory molecules in chronic liver diseases, whose end stage is hepatic fibrosis, a major global health burden. Pharmacological strategies for prevention or treatment of hepatic fibrosis are still limited, what makes it necessary to establish a better understanding of the molecular mechanisms underlying its pathogenesis. In this context, we have recently shown that cyclooxygenase-2 (COX-2) expression in hepatocytes restricts activation of hepatic stellate cells (HSCs), a pivotal event in the initiation and progression of hepatic fibrosis. Here, we evaluated the role of COX-2 in the regulation of a specific set of miRNAs on a mouse model of CCl4 and bile duct ligation (BDL)-induced liver fibrosis. Our results provide evidence that COX-2 represses miR-23a-5p and miR-28-5p expression in HSC. The decrease of miR-23a-5p and miR-28-5p expression promotes protection against fibrosis by decreasing the levels of pro-fibrogenic markers α-SMA and COL1A1 and increasing apoptosis of HSC. Moreover, we demonstrate that serum levels of miR-28-5p are decreased in patients with chronic liver disease. These results suggest a protective effect exerted by COX-2-derived prostanoids in the process of hepatofibrogenesis., This work was supported by Financing Program for short stays abroad for Assistant Researchers (CONICET-Argentina) and i-COOP2016-20213 to D.F.; SAF2014-52492 (MINECO, Spain) to L.B.; CIBERcv and CIBERehd (ISCIII, Spain) to L.B., P.M.S. and M.C.; PI13/01299 (ISCIII, Spain) to C.G-M.; SAF2013-43713-R, SAF2016-75004-R and SAF2015-70270-REDT (MINECO, Spain) to L.B., P.M.S. and M.C. We thank FEDER for financial support., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort

  • Prieto, Patricia
  • Jaén, Rafael I.
  • Calle, Daniel
  • Gómez-Serrano, María
  • Núñez, Estefanía
  • Fernández-Velasco, María
  • Martín-Sanz, Paloma
  • Alonso, Sergio
  • Vázquez, Jesús
  • Cerdán, Sebastián
  • Peinado, Miguel A.
  • Boscá, Lisardo
[Background]: Colorectal cancer (CRC) is the second most common cause of cancer death worldwide. It is broadly described that cyclooxygenase-2 (COX-2) is mainly overexpressed in CRC but less is known regarding post-translational modifications of this enzyme that may regulate its activity, intracellular localization and stability. Since metabolic and proteomic profile analysis is essential for cancer prognosis and diagnosis, our hypothesis is that the analysis of correlations between these specific parameters and COX-2 state in tumors of a high number of CRC patients could be useful for the understanding of the basis of this cancer in humans., [Aim]: To analyze COX-2 regulation in colorectal cancer and to perform a detailed analysis of their metabolic and proteomic profile., [Methods]: Biopsies from both healthy and pathological colorectal tissues were taken under informed consent from patients during standard colonoscopy procedure in the University Hospital of Bellvitge (Barcelona, Spain) and Germans Trias i Pujol University Hospital (Campus Can Ruti) (Barcelona, Spain). Western blot analysis was used to determine COX-2 levels. Deglycosylation assays were performed in both cells and tumor samples incubating each sample with peptide N-glycosidase F (PNGase F). Prostaglandin E2 (PGE2) levels were determined using a specific ELISA. 1H high resolution magic angle spinning (HRMAS) analysis was performed using a Bruker AVIII 500 MHz spectrometer and proteomic analysis was performed in a nano-liquid chromatography-tandem mass spectrometer (nano LC-MS/MS) using a QExactive HF orbitrap MS., [Results]: Our data show that COX-2 has a differential expression profile in tumor tissue of CRC patients vs the adjacent non-tumor area, which correspond to a glycosylated and less active state of the protein. This fact was associated to a lesser PGE2 production in tumors. These results were corroborated in vitro performing deglycosylation assays in HT29 cell line where COX-2 protein profile was modified after PNGase F incubation, showing higher PGE2 levels. Moreover, HRMAS analysis indicated that tumor tissue has altered metabolic features vs non-tumor counterparts, presenting increased levels of certain metabolites such as taurine and phosphocholine and lower levels of lactate. In proteomic experiments, we detected an enlarged number of proteins in tumors that are mainly implicated in basic biological functions like mitochondrial activity, DNA/RNA processing, vesicular trafficking, metabolism, cytoskeleton and splicing., [Conclusion]: In our colorectal cancer cohort, tumor tissue presents a differential COX-2 expression pattern with lower enzymatic activity that can be related to an altered metabolic and proteomic profile., MINECO, No. SAF2017-82436R, SAF2016-75004R, RTC-2017-6283-1, PRB3 (IPT17/0019-ISCIII-SGEFI/ERDF) and BIO2015-67580P; Comunidad de Madrid, No. S2017/BMD-3686; Fundación Ramón Areces, No. 2016/CIVP18A3864; Instituto de Salud Carlos III, Spain, CIBERCV, No. CB/11/00222 and CB16/11/00277; FEDER, CIBEREHD; the Ministerio de Ciencia, Innovación y Universidades (MCNU); the Pro CNIC Foundation; and Severo Ochoa Center of Excellence, No. SEV-2015-0505., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Role of COX-2 in liver mitochondrial function

  • Fuertes-Agudo, Marina
  • Cucarella, Carme
  • Brea, Rocío
  • Casanova, Natalia
  • Boscá, Lisardo
  • Martín-Sanz, Paloma
  • Casado, Marta
Póster presentado al 42nd Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM), celebrado en Madrid del 16 al 19 de julio de 2019., Liver and heart are two principal organs in the body. Although their physiology is extremely different, both tissues have in common that adult hepatocytes and cardiomyocytes fail to induce COX-2 expression, the key enzyme in the synthesis of prostaglandins, regardless of the pro-inflammatory factors used. In both cell types, COX-2 expression is restricted to those situations in which dedifferentiation or proliferation occur. In parallel studies, using mice genetically modified to selectively express hCOX-2 in hepatocytes and cardiomyocytes, we have demonstrated an increased tolerance to ischemia-reperfusion injury (IRI) with an increased functional recovery, a diminished cellular necrosis and less inflammation. It is known that mitochondria have a major role in IRI damage by increasing oxidative stress, decoupling metabolic state and inducing apoptosis. In this work, we analyse different aspects in order to characterize the impact of COX-2 in mitochondrial function., SAF2016-75004-R and BES-2017-081928, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Cyclooxygenase-2 expression in hepatocytes protects against hepatic ischemia/reperfusion injury in mice

  • Motiño, Omar
  • Francés, Daniel E.
  • Casanova, Natalia
  • Cucarella, Carme
  • Fuertes-Agudo, Marina
  • Flores, Juana María
  • Olmedilla, Luis
  • Pérez Peña, José
  • Bañares, Rafael
  • Boscá, Lisardo
  • Casado, Marta
  • Martín-Sanz, Paloma
Trabajo presentado al 41 Congreso de la Sociedad Española de Bioquímica y Biología Molecular (SEBBM), celebrado en Santander del 10 al 13 de septiembre de 2018., Liver ischemia and reperfusion injury (IRI) remains a serious clinical problem affecting liver transplantation outcomes. IRI causes up to 10% of early organ failure and predisposes to chronic rejection. Cyclooxygenase-2 (COX-2) is involved in different liver diseases but the significance of COX-2 in liver IRI is a matter of controversy. This study was designed to elucidate the role of COX-2 expression in hepatocytes in the pathogenesis of liver IRI. In the present work hepatocyte-specific COX-2 transgenic mice (hCOX-2-Tg) and their wild-type (Wt) littermates were subjected to partial IRI and the results show that hCOX-2-Tg exhibited lower grades of necrosis and inflammation than Wt mice in part by reduced recruitment and infiltration of hepatic macrophages and netrophils with a corresponding decrease in serum levels of pro-inflammatory cytokines. Moreover hCOX-2-Tg mice showed a significant attenuation of the IRI-induced increase in oxidative stress and hepatic apoptosis an increase in autophagic flux and a decrease in endoplasmic reticulum (ER) stress comparing with that observed in Wt mice. Preconditioning of Wt mice resembles the beneficial effects of hCOX-2-Tg mice in IRI due to an increase in endogenous COX-2 expression. Furthermore measurement of PGE2 levels in plasma from patients who underwent orthotopic liver transplantation revealed a significantly negative correlation between PGE2 levels and graft function and time of ischemia. Overall the data support the view of the beneficial effects of hepatic COX-2 dependent prostaglandins after liver IRI., This work was supported by i‐COOP2016‐20213 (CSIC) to D.F., P.M.S; SAF2014‐52492 (MINECO, Spain) to L.B.; CIBERcv and CIBERehd (ISCIII, Spain) to L.B., P.M.S and M.C.; SAF2016‐75004‐R (MINECO, Spain) to P.M.S. and M.C. M F‐A. is recipient of FPI fellowship from MINECO (BES‐2017‐081928)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Protective role of hepatocyte cyclooxygenase-2 expression against liver ischemia-reperfusion injury in mice

  • Motiño, Omar
  • Francés, Daniel E.
  • Casanova, Natalia
  • Fuertes-Agudo, Marina
  • Cucarella, Carme
  • Flores, Juana María
  • Vallejo-Cremades, Maria T.
  • Olmedilla, Luis
  • Pérez Peña, José
  • Boscá, Lisardo
  • Casado, Marta
  • Martín-Sanz, Paloma
Liver ischemia and reperfusion injury (IRI) remains a serious clinical problem affecting liver transplantation outcomes. IRI causes up to 10% of early organ failure and predisposes to chronic rejection. Cyclooxygenase‐2 (COX‐2) is involved in different liver diseases, but the significance of COX‐2 in IRI is a matter of controversy. This study was designed to elucidate the role of COX‐2 induction in hepatocytes against liver IRI. In the present work, hepatocyte‐specific COX‐2 transgenic mice (hCOX‐2‐Tg) and their wild‐type (Wt) littermates were subjected to IRI. hCOX‐2‐Tg mice exhibited lower grades of necrosis and inflammation than Wt mice, in part by reduced hepatic recruitment and infiltration of neutrophils, with a concomitant decrease in serum levels of proinflammatory cytokines. Moreover, hCOX‐2‐Tg mice showed a significant attenuation of the IRI‐induced increase in oxidative stress and hepatic apoptosis, an increase in autophagic flux, and a decrease in endoplasmic reticulum stress compared to Wt mice. Interestingly, ischemic preconditioning of Wt mice resembles the beneficial effects observed in hCOX‐2‐Tg mice against IRI due to a preconditioning‐derived increase in endogenous COX‐2, which is mainly localized in hepatocytes. Furthermore, measurement of prostaglandin E2 (PGE2) levels in plasma from patients who underwent liver transplantation revealed a significantly positive correlation of PGE2 levels and graft function and an inverse correlation with the time of ischemia. Conclusion: These data support the view of a protective effect of hepatic COX‐2 induction and the consequent rise of derived prostaglandins against IRI., Supported by project S2017/BMD-3686 (to P.M.S. and L.B.), CSIC (i-COOP2016-20213, to D.F. and P.M.S.), MICINN (SAF2014-52492, to L.B.; SAF2016-75004-R, to P.M.S. and M.C.; FPI fellowship BES-2017-081928, to M.F.-A.), ISCIII (CIBERcv and CIBERehd, to L.B., P.M.S., and M.C.), and FEDER., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM-1

  • González-Ramos, Silvia
  • Paz-García, Marta
  • Rius, Cristina
  • Monte-Monge, Alberto del
  • Rodríguez-Sinovas, Cristina
  • Fernández-García, Victoria
  • Andrés, Vicente
  • Martínez-González, José
  • Lasunción, Miguel A.
  • Martín-Sanz, Paloma
  • Soehnlein, Oliver
  • Boscá, Lisardo
Atherosclerosis is a chronic disease characterized by vascular lipid retention and inflammation, and pattern recognition receptors (PRRs) are important contributors in early stages of the disease. Given the implication of the intracellular PRR nucleotide-binding oligomerization domain 1 (NOD1) in cardiovascular diseases, we investigated its contribution to early atherosclerosis. We evidenced NOD1 induction in atherosclerotic human and mouse tissues, predominantly in vascular endothelial cells. Accordingly, NOD1 genetic inactivation in Apoe-/- mice reduced not only atherosclerosis burden, but also monocyte and neutrophil accumulation in atheromata. Of note, in the presence of either peptidoglycan or oxidized LDLs, endothelial NOD1 triggered VCAM-1 up-regulation through the RIP2-NF-¿B axis in an autocrine manner, enhancing firm adhesion of both sets of myeloid cells to the inflamed micro- and macrovasculature in vivo. Our data define a major proatherogenic role for endothelial NOD1 in early leukocyte recruitment to the athero-prone vasculature, thus introducing NOD1 as an innovative therapeutic target and potential prognostic molecule, This work was supported bythe the Ministry of Science, Innovation and Universities(Grants SAF2015-64767-R, SAF2016-79490-R, SAF2015-70747-R, SAF2016-75004-R, SAF2017-82436-R/RTC2017-6283-1), the Center for Biomedical Research Network Consortium in Cardiovascular Diseases (Grants CB16/11/00257, CB16/11/00405, CB/11/00222), Community of Madrid Grant BMD/3686, the German Research Foundation (Grants SFB914 TPA02/B08/B09/Z03, SFB1123 TP A06/B05/B08/Z01), and the Netherlands Organization for Scientific Research (VIDI proj-ect 91712303). This project was also financed, in part, by theEuropean Regional Development Fund. O.S. and L.B. con-tributed equally as senior authors.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

NOD1 deficiency promotes an imbalance of thyroid hormones and microbiota homeostasis in mice fed high fat diet

  • González-Ramos, Silvia
  • Paz-García, Marta
  • Fernández-García, Victoria
  • Portune, Kevin J.
  • Acosta Medina, Emilio F.
  • Sanz Herranz, Yolanda
  • Castrillo, Antonio
  • Martín-Sanz, Paloma
  • Obregón, María Jesús
  • Boscá, Lisardo
The contribution of the nucleotide-binding oligomerization domain protein NOD1 to obesity has been investigated in mice fed a high fat diet (HFD). Absence of NOD1 accelerates obesity as early as 2 weeks after feeding a HFD. The obesity was due to increases in abdominal and inguinal adipose tissues. Analysis of the resting energy expenditure showed an impaired function in NOD1-deficient animals, compatible with an alteration in thyroid hormone homeostasis. Interestingly, free thyroidal T4 increased in NOD1-deficient mice fed a HFD and the expression levels of UCP1 in brown adipose tissue were significantly lower in NOD1-deficient mice than in the wild type animals eating a HFD, thus contributing to the observed adiposity in NOD1-deficient mice. Feeding a HFD resulted in an alteration of the proinflammatory profile of these animals, with an increase in the infiltration of inflammatory cells in the liver and in the white adipose tissue, and an elevation of the circulating levels of TNF-α. In addition, alterations in the gut microbiota in NOD1-deficient mice correlate with increased vulnerability of their ecosystem to the HFD challenge and affect the immune-metabolic phenotype of obese mice. Together, the data are compatible with a protective function of NOD1 against low-grade inflammation and obesity under nutritional conditions enriched in saturated lipids. Moreover, one of the key players of this early obesity onset is a dysregulation in the metabolism and release of thyroid hormones leading to reduced energy expenditure, which represents a new role for these hormones in the metabolic actions controlled by NOD1., This work was supported by Grants SAF2017-82436R, AGL2017-88801-P and SAF2016-75004R from MINECO/AEI/FEDER/EU, S2017/BMD-3686 from Comunidad de Madrid, CIVP18A3864 from Fundación Ramón Areces and CIBERCV and CIBERHED (funded by the Instituto de Salud Carlos III) and Fondos FEDER., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Deletion or Inhibition of NOD1 Favors Plaque Stability and Attenuates Atherothrombosis in Advanced Atherogenesis

  • González-Ramos, Silvia
  • Fernández-García, Victoria
  • Recalde, Miriam
  • Rodríguez-Sinovas, Cristina
  • Martínez-González, José
  • Andrés, Vicente
  • Martín-Sanz, Paloma
  • Boscá, Lisardo
© 2020 by the authors., Atherothrombosis, the main cause of acute coronary syndromes (ACS), is characterized by the rupture of the atherosclerotic plaque followed by the formation of thrombi. Fatal plaque rupture sites show large necrotic cores combined with high levels of inflammation and thin layers of collagen. Plaque necrosis due to the death of macrophages and smooth muscle cells (SMCs) remains critical in the process. To determine the contribution of the innate immunity receptor NOD1 to the stability of atherosclerotic plaque, Apoe−/− and Apoe−/− Nod1−/− atherosclerosis prone mice were placed on a high-fat diet for 16 weeks to assess post-mortem advanced atherosclerosis in the aortic sinus. The proliferation and apoptosis activity were analyzed, as well as the foam cell formation capacity in these lesions and in primary cultures of macrophages and vascular SMCs obtained from both groups of mice. Our results reinforce the preeminent role for NOD1 in human atherosclerosis. Advanced plaque analysis in the Apoe−/− atherosclerosis model suggests that NOD1 deficiency may decrease the risk of atherothrombosis by decreasing leukocyte infiltration and reducing macrophage apoptosis. Furthermore, Nod1−/− SMCs exhibit higher proliferation rates and decreased apoptotic activity, contributing to thicker fibrous caps with reduced content of pro-thrombotic collagen. These findings demonstrate a direct link between NOD1 and plaque vulnerability through effects on both macrophages and SMCs, suggesting promising insights for early detection of biomarkers for treating patients before ACS occurs., This work was supported by the Ministerio Economía, Industria y Competitividad/Agencia Estatal de Investigación (SAF2016-79490-R, RTI2018-094727-B-100, SAF2015-64767-R, SAF2016-75004-R, SAF2017-82436-R/RTC2017-6283-1, PID2019-108977RB-100), Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CB16/11/00405, CB16/11/00257, CB16/11/00222), Fundación Ramón Areces (CIUP18A3864), Consorcio de Investigación en Red de la Comunidad de Madrid, S2017/BMD-3686 and Fondo Europeo de Desarrollo Regional. The CNIC is supported by the Ministerio de Ciencia e Innovación, the Instituto de Salud Carlos III and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant SEV-2015-0505)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Metabolic plasticity is an essential requirement of acquired tyrosine kinase inhibitor resistance in Chronic Myeloid Leukemia

  • Contreras Mostazo, Miriam G.
  • Kurrle, Nina
  • Casado, Marta
  • Fuhrmann, Dominik
  • Alshamleh, Islam
  • Häupl, Björn
  • Martín-Sanz, Paloma
  • Brüne, Bernhard
  • Serve, Hubert
  • Schwalbe, Harald
  • Schnütgen, Frank
  • Marín, Silvia
  • Cascante, Marta
© 2020 by the authors., Tyrosine kinase inhibitors (TKIs) are currently the standard chemotherapeutic agents for the treatment of chronic myeloid leukemia (CML). However, due to TKI resistance acquisition in CML patients, identification of new vulnerabilities is urgently required for a sustained response to therapy. In this study, we have investigated metabolic reprogramming induced by TKIs independent of BCR-ABL1 alterations. Proteomics and metabolomics profiling of imatinib-resistant CML cells (ImaR) was performed. KU812 ImaR cells enhanced pentose phosphate pathway, glycogen synthesis, serine-glycine-one-carbon metabolism, proline synthesis and mitochondrial respiration compared with their respective syngeneic parental counterparts. Moreover, the fact that only 36% of the main carbon sources were utilized for mitochondrial respiration pointed to glycerol-phosphate shuttle as mainly contributors to mitochondrial respiration. In conclusion, CML cells that acquire TKIs resistance present a severe metabolic reprogramming associated with an increase in metabolic plasticity needed to overcome TKI-induced cell death. Moreover, this study unveils that KU812 Parental and ImaR cells viability can be targeted with metabolic inhibitors paving the way to propose novel and promising therapeutic opportunities to overcome TKI resistance in CML., M.G. Contreras Mostazo and I. Alshamleh were supported by the EU grant HaemMetabolome H2020-MSCA-ITN-2015-675790. H. Schwalbe, H. Serve, F. Schnütgen, S. Marin and M. Cascante acknowledge support from the European Commission (HaemMetabolome [EC-675790]). M. Cascante and S. Marin acknowledge the Spanish Ministerio de Economia y Competitividad (MINECO)-European Commission FEDER funds—“Una manera de hacer Europa” (SAF2017-89673-R), the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) Generalitat de Catalunya (2017SGR1033) and CIBERehd (CB17/04/00023) (ISCIII, Spain). M. Cascante also received support through the prize “ICREA Academia” for excellence in research, funded by ICREA foundation–Generalitat de Catalunya. F. Schnütgen was supported by the Wilhelm Sander-Foundation (2015.138.1) and the Deutsche Forschungsgemeinschaft (SCHN1166/4-1). H. Schwalbe acknowledges support for the Center for Biomolecular Magnetic Resonance (BMRZ) by state of Hesse. M. Casado and P. Martín-Sanz acknowledge support from SAF2016-75004-R (MINECO, Spain, AEI/FEDER, UE), PID2019-108977RB-I00 (MICINN, Spain,AEI/FEDER, UE), and CIBERehd (CB06/04/1069) (ISCIII, Spain). D. Fuhrmann, B. Brüne, N. Kurrle and H. Serve acknowledge Deutsche Forschungsgemeinschaft (SFB 815, TP A08, TP A10).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Hepatic COX-2 expression protects mice from an alcohol-high fat dietinduced metabolic disorder by involving protein acetylation related energy metabolism

  • Chen, Minjie
  • Sun, Xicui
  • Wei, Wei
  • Cucarella, Carme
  • Martín-Sanz, Paloma
  • Casado, Marta
  • Pi, Liya
  • Ren, Bin
  • Cao, Qi
12 páginas, 5 figuras, 2 tablas, Purpose: A diet high in fat and ethanol often results in chronic metabolic disorder, hepatic steatosis, and liver inflammation. Constitutive hepatic cyclooxygenase-2 (COX-2) expression could protect from high fat-induced metabolism disturbance in a murine model. In this study, we explored the influence of hCOX-2 transgenic [TG] to high fat with ethanol-induced metabolic disorder and liver injury using a mouse animal model. Methods: 12-week-old male hepatic hCOX-2 transgenic (TG) or wild type mice (WT) were fed either a high fat and ethanol liquid diet (HF+Eth) or a regular control diet (RCD) for 5 weeks (four groups: RCD/WT, RCD/TG; HF+Eth/TG, HF+Eth/WT). We assessed metabolic biomarkers, cytokine profiles, histomorphology, and gene expression to study the impact of persistent hepatic COX-2 expression on diet-induced liver injury. Results: In the HF+Eth diet, constitutively hepatic human COX-2 expression protects mice from body weight gain and white adipose tissue accumulation, accompanied by improved IPGTT response, serum triglyceride/cholesterol levels, and lower levels of serum and liver inflammatory cytokines. Histologically, hCOX-2 mice showed decreased hepatic lipid droplets accumulation, decreased hepatocyte ballooning, and improved steatosis scores. Hepatic hCOX-2 overexpression enhanced AKT insulin signaling and increased fatty acid synthesis in both RCD and HF+Eth diet groups. The anti-lipogenic effect of hCOX-2 TG in the HF+Eth diet animals was mediated by increasing lipid disposal through enhanced β-oxidation via elevations in the expression of PPARα and PPARγ, and increased hepatic autophagy as assessed by the ratio of autophagy markers LC3 II/I in hepatic tissue. Various protein acetylation pathway components, including HAT, HDAC1, SIRT1, and SNAIL1, were modulated in hCOX-2 TG mice in either RCD or HF+Eth diet. Conclusions: Hepatic human COX-2 expression protected mice from the metabolic disorder and liver injury induced by a high fat and ethanol diet by enhancing hepatic lipid expenditure. Epigenetic reprogramming of diverse metabolic genes might be involved in the anti-lipogenic effect of COX-2., This work was supported by NIH grant (K08AA024895 to Q.C), Department Chair Research Fund of UMB (Q.C), GE Healthcare/ RSNA Research Resident Grant (#RR1250 to Q.C), Innovation Seed Grant of UMB (Q.C), Ministry of Economy and Competitiveness (MINECO, Spain. SAF2016-75004-R to P.M.S. and M.C) and NIH grant (1R01AA028035-01 to L.P)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Chronic treatment with acetaminophen protects against liver aging by targeting inflammation and oxidative stress

  • Brea, Rocío
  • Valdecantos, Pilar
  • Rada, Patricia
  • Alén, Rosa
  • García-Monzón, Carmelo
  • Boscá, Lisardo
  • Fuertes-Agudo, Marina
  • Casado, Marta
  • Martín-Sanz, Paloma
  • Valverde, Ángela M.
28 páginas, 7 figuras, 2 tablas, The liver exhibits a variety of functions that are well-preserved during aging. However, the cellular hallmarks of aging increase the risk of hepatic alterations and development of chronic liver diseases. Acetaminophen (APAP) is a first choice for relieving mild-to-moderate pain. Most of the knowledge about APAP-mediated hepatotoxicity arises from acute overdose studies due to massive oxidative stress and inflammation, but little is known about its effect in age-related liver inflammation after chronic exposure. Our results show that chronic treatment of wild-type mice on the B6D2JRcc/Hsd genetic background with APAP at an infratherapeutic dose reduces liver alterations during aging without affecting body weight. This intervention attenuates age-induced mild oxidative stress by increasing HO-1, MnSOD and NQO1 protein levels and reducing ERK1/2 and p38 MAPK phosphorylation. More importantly, APAP treatment counteracts the increase in Cd8+ and the reduction in Cd4+ T lymphocytes observed in the liver with age. This response was also found in peripheral blood mononuclear cells. In conclusion, chronic infratherapeutic APAP treatment protects mice from age-related liver alterations by attenuating oxidative stress and inflammation., SAF2016-75004-R, PID2019-108977RB-100 (AEI/FEDER, UE) to P. M-S. and M.C. and S2017/BMD-3686 (CM) to P. M-S, RTI2018-094052-B-100 (AEI/FEDER, UE), S2017/BMD-3684 (CM), Fundación Ramón Areces (Spain) and CIBERdem (ISCIII) to A.M.V., and PI17/00535 (ISCIII/FEDER, UE) to C. G-M., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Role of cyclooxygenase 2 (COX-2) in liver mitochondrial function after ischemia-reperfusion injury

  • Fuertes-Agudo, Marina
  • Cucarella, Carme
  • Brea, Rocío
  • Boscá, Lisardo
  • Martín-Sanz, Paloma
  • Casado, Marta
Póster presentado al: Liver Meeting AASLD 2021: American Association fort eh Study of Liver Diseases. (Anaheim, CA, USA and virtual), 12-15 de novembre 2021 Abstract: 470, pag. 293A, In this work, we analyzed different aspects in order to characterize the impact of COX-2 in mitochondrial function after IRI., This work was supported by SAF2016-75004-R (MINECO, Spain) and PID2019-108977RB-I00 (MICINN, Spain), CIBERehd (ISCIII, Spain). M F-A. is recipient of FPI fellowship from MINECO (BES-2017-081928), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Liver spheroids: a robust human in vitro system for testing the therapeutic options of cyclooxygenase 2 in NAFLD/NASH

  • Fuertes-Agudo, Marina
  • Brea, Rocío
  • Luque-Tévar, María
  • Cucarella, Carme
  • Martín-Sanz, Paloma
  • Casado, Marta
Trabajo presentado en el FASEB Science Research Conference: The Liver Biology Conference: Fundamental Mechanisms and Translational Applications,, [Background]: NAFLD is the most prevalent chronic liver disease in the world and is considered the hepatic manifestation of metabolic syndrome. It begins with an accumulation of fat in the liver, which can lead to cellular damage and inflammation (NASH) and, if unaddressed, progresses to liver fibrosis, where parenchymal tissue is replaced by extracellular matrix. Cyclooxygenase (COX) is a key regulatory step in the biosynthesis of prostanoids. The COX-2 isoform is expressed and induced by different stimuli in various tissues and cell types; however, in liver, COX-2 expression is restricted to those situations in which proliferation or dedifferentiation occur (1). Our previous results revealed that COX-2 expression in hepatocytes protects against hyperglycemia-induced liver damage and against peripheral insulin resistance and adiposity in mice subjected to a high-fat diet (2). Furthermore, COX-2 expression in hepatocytes protects against experimental nonalcoholic steatohepatitis and fibrosis in mice (3). [Aims]: Since our previous results are performed in mice, we wanted to bridge from animal models to a more translational research, close to human. Therefore, we wanted to establish an in vitro model based on 3D human cell culture to evaluate the role of COX-2, specifically the role of prostaglandins, in a human model of NAFLD/NASH. [Methods]: To analyze the role of COX-2 in steatosis and fibrosis, we established a 3D spheroid culture composed of HepG2 and LX-2 cells. These spheroids were treated with palmitic acid and TGF¿ to induce NAFLD/NASH and fibrosis, respectively. They were then treated with PGE2 to evaluate their effect in this model. [Results]: In summary, our results demonstrate that PGE2 treatment reduces lipid levels after fatty acid exposure. Moreover, it reduces fatty acid-induced cell damage and insulin resistance. Furthermore, PGE2 slows fibrotic progression by decreasing stellate cells activation after TGF¿ stimulation. Conclusions: These preliminary results indicate that a therapeutic strategy for the treatment of NAFLD/NASH may be COX-2-derived prostaglandin therapy., This work was supported by SAF2016-75004-R and PID2019-108977RB-I00 (MINECO, Spain) and CIBERehd (ISCIII, Spain). M F-A. and M L-T are recipient of FPI fellowship from MINECO (BES-2017-081928 and PRE2020-094885, respectively). We thank FEDER for financial support.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

Role of cyclooxygenase-2 in ischemia-reperfusion injury in the liver

  • Fuertes-Agudo, Marina
Tesis doctoral, 217 p., [EN] Hepatic ischemia-reperfusion (I/R) injury (IRI) is a major cause of mortality and morbidity in liver resection and liver transplantation. During the hypoxia, the liver remains without oxygen supply, shifting its metabolism and stopping the ATP synthesis. Paradoxically, the restoration of oxygen flow causes the most damage with an activation of the immune system that will generate a burst of reactive species of oxygen (ROS) that will cause cell and tissue damage. Cyclooxygenase-2 (COX-2) is a key enzyme in prostaglandin biosynthesis and its importance in IRI is controversial. PGE2, prostaglandin E2, is the main product of COX-2, and is mainly involved in mediating pathological processes such as inflammation, fever and pain. While the use of NSAIDs, specific COX inhibitors, points to a beneficial effect in the resolution of the inflammatory process, several studies support the idea of an anti-inflammatory role of COX-2. In fact, previous studies have shown that COX-2 overexpression in hepatocytes protects mice from apoptosis and cellular stress, as well as reducing the inflammatory response, in different liver disease models. In this PhD thesis, a hepatocyte-specific COX-2 transgenic mouse (h-COX-2 Tg) was used to elucidate the role and involvement of COX-2 in IRI. Wild type (Wt) and h-COX-2 Tg animals were subjected to 90 min of ischemia, followed by 4 or 24 h of reperfusion. Comparing h-COX-2 Tg animals with their Wt littermates, cellular and tissue damage resulting from IRI is attenuated. Among these pathways, the inflammatory cascade is less activated, with less pro-inflammatory cytokine release, less hepatic recruitment and neutrophil infiltration. Necrosis and apoptosis pathways are also attenuated such as reduced endoplasmic reticulum stress, and increased autophagy. The antioxidant response appears to be enhanced in the context of COX-2 overexpression and total ROS production is also lower, contributing to less tissue damage. When Wt animals are subjected to preconditioning (PC), endogenous COX-2 is induced at higher levels than without PC, and these livers show less damage, attenuated inflammation, and an enhanced antioxidant response. Furthermore, the role of COX-2 in this observed protection has been shown to be specific, as its inhibition with DFU, reverses the observed effects, and matched the damage caused to Wt animals. Mitochondria are central players in the pathophysiology of IRI. In this regard, mitochondrial function is preserved in COX-2-overexpressing livers, as can be demonstrated by a conserved mitochondrial membrane potential and a preserved respiratory rate. These results can be explained by a stabilisation of mitochondrial cristae, invaginations of the inner mitochondrial membrane (IMM) that maintained through interactions of various isoforms of OPA1. Its processing is mediated by proteases, such as OMA1, which acts under certain stimuli. In h-COX-2 Tg mice, there is a reduced OPA1 processing that correlates with attenuated OMA1 activity, showing a stabilisation of cristae in the context of COX-2 overexpression after I/R. On the other hand, a retrospective study was conducted in patients who had undergone liver transplantation. In this part of the study, PGE2 levels were analysed and correlated with liver functions after transplantation. This analysis shows that the presence of PGE2 in the plasma of recipients correlates with a better prognosis, while lower PGE2 levels are associated with early graft dysfunction. All these results present COX-2 as a new player in liver protection after I/R, showing an anti-inflammatory and antioxidant role, as well as reducing mitochondrial damage, cell stress and cell death. Furthermore, it is shown how COX-2-derived prostaglandins under physiological conditions can play a protective role in cases of liver transplant., [ES] La lesión por isquemia-reperfusión (I/R) hepática (IRI) es una causa importante de mortalidad y morbilidad en la resección hepática y el trasplante de hígado. Durante la hipoxia, el hígado permanece sin oxígeno, cambiando su metabolismo y parando la síntesis de ATP. Paradójicamente, el restablecimiento del flujo de oxígeno causa más daño, activando el sistema inmunitario que generará una gran cantidad de especies reactivas de oxígeno (ROS) causando daño celular y tisular. La ciclooxigenasa-2 (COX-2) es una enzima clave en la biosíntesis de prostaglandinas y su importancia en la IRI es controvertida. La PGE2, prostaglandina E2, es el principal producto de la COX-2, y participa en la mediación de procesos patológicos como la inflamación, la fiebre y el dolor. El uso de AINEs, inhibidores específicos de la COX, apunta a un efecto beneficioso en la resolución del proceso inflamatorio, pero cada vez más estudios apoyan el papel antiinflamatorio de la COX-2. De hecho, estudios previos han demostrado que la sobreexpresión de COX-2 en hepatocitos protege a los ratones de la apoptosis y el estrés celular, además de reducir la respuesta inflamatoria en diferentes modelos de enfermedad hepática. En esta tesis doctoral, se utilizó un ratón transgénico que sobreexpresa COX-2 en los hepatocitos (h-COX-2 Tg) para dilucidar el papel y la implicación de la COX-2 en la IRI. Los animales de tipo silvestre (Wt) y h-COX-2 Tg fueron sometidos a 90 min de isquemia, seguidos de 4 o 24 h de reperfusión. Comparando los animales h-COX-2 Tg con sus hermanos Wt, el daño celular y tisular se atenúa tras la IRI. Entre las distintas vías modificadas, la cascada inflamatoria está menos activada, con menor liberación de citoquinas pro-inflamatorias, menor reclutamiento hepático, e infiltración de neutrófilos. Las vías de necrosis y apoptosis también se atenúan así como se reduce del estrés del retículo endoplásmico, y aumenta la autofagia. La respuesta antioxidante se potencia en el contexto de la sobreexpresión de COX-2 y la producción total de ROS es menor, lo que contribuye a un menor daño tisular. Cuando los animales Wt se someten un pre-condicionamiento (PC), la COX-2 endógena se induce a niveles más altos que sin PC, mostrando menos daño, una inflamación atenuada, y una respuesta antioxidante mejorada. Además, se muestra que el papel de la COX-2 en esta protección es específico, ya que su inhibición con DFU revierte los efectos observados e iguala el daño causado a los animales Wt. Las mitocondrias son actores centrales en la fisiopatología de la IRI. En este sentido, la función mitocondrial está preservada en los hígados que sobreexpresan COX-2, con un potencial de membrana mitocondrial conservado y una tasa respiratoria preservada. Estos efectos pueden explicarse por una estabilización de las crestas mitocondriales, invaginaciones de la membrana mitocondrial interna (IMM) que se mantienen mediante interacciones de varias isoformas de la proteína OPA1. Su procesamiento está mediado por proteasas, como OMA1. En ratones h-COX-2 Tg hay un menor procesamiento de OPA1, que se correlaciona con una actividad atenuada de OMA1. Por otro lado, se realizó un estudio retrospectivo en pacientes que habían sido sometidos a un trasplante hepático. Se analizaron los niveles de PGE2 y se correlacionaron con las funciones hepáticas tras el trasplante. Este análisis muestra que la presencia de PGE2 en el plasma de los pacientes receptores se correlaciona con un mejor pronóstico, mientras que unos niveles más bajos de PGE2 se asocian con una disfunción precoz del injerto. Todos estos resultados presentan a la COX-2 como un nuevo actor en la protección del hígado tras I/R, mostrando un papel antiinflamatorio y antioxidante, así como reduciendo el daño mitocondrial, el estrés celular y la muerte celular. Además, se demuestra cómo las prostaglandinas derivadas de la COX-2 en condiciones fisiológicas pueden desempeñar un papel protector en casos de trasplante hepático., This work has been carried out with the financial support of the Spanish Ministry of Science and Innovation (SAF2016-75004R and PID2019-108977RB-100), the CIBERehd (Centro de Investigaciones Biomédicas En Red de Enfermedades Hepáticas y Digestivas) and the COST Action (CA15203 - Mitochondrial mapping: Evolution - Age - Gender - Lifestyle - Environment (MITOEAGLE)). Marina Fuertes Agudo benefited from a pre-doctoral FPI contract (BES-2017- 081928) associated with the SAF2016-75004R project. She spent 3 months in the laboratory of Dr. Pau Sancho Bru at the Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS, Barcelona, Spain) funded by a short stay grant awarded by the CIBERehd and 3 months in the laboratory of Dr. Anne Dubart Kupperschmitt and Dr. Jean Charles Duclos Vallée at the Institut Nationale de la Santé et la Recherche Médicale (INSERM, Villejuif, France) funded by a short stay grant awarded by the European Molecular Biology Organisation (EMBO, SEG_9771)., Peer reviewed